aTyr Pharma (LIFE) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
aTyr Pharma (LIFE) PT Lowered to $1 at BMO Capital
August 15, 2018 7:29 AM EDTBMO Capital analyst Matthew Luchini lowered the price target on aTyr Pharma (NASDAQ: LIFE) to $1.00 (from $2.00) while maintaining a Market Perform rating.
... More